I re-entered into OXGN today because I think they can surprise at ASCO and I guess it couldn't harm that they also have Tamar on their board..
If what IDIX wanted was a director with experience in biotech partnerships and M&A transactions, a better pick than Ms. Howson would be hard to find. She has held senior business-development positions at BMY, LEXG, and SmithKline Beecham (now part of GSK). Howson also has an engineering degree from Technion in Israel, one of the world’s premiere academic institutions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.